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Abstract
Adult rhabdomyosarcoma (RMS) in the urinary bladder is rare, and is the subject of case reports and small series. It
consists of sheets of small round blue cells with high nuclear cytoplasmic ratio, brisk mitosis and apoptosis. In this
study, we reported one case of pure rhabdomyosarcoma and two cases of urothelial carcinomas with extensive
rhabdomyosarcomatous differentiation. In addition, their immunohistochemical profile was compared to that of
small cell carcinoma of the bladder. Our study showed that sufficient sampling was critical for the diagnosis of
urothelial carcinoma with extensive rhabdomyosarcomatous differentiation. As adult RMS in the bladder and
urothelial carcinoma with rhabdomyosarcomatous differentiation shared morphological features with small cell
carcinoma of the bladder, appropriate immunohistochemical stains were necessary in the differential diagnosis. We
showed both rhabdomyosarcoma and rhabdomyosarcomatous areas of the urothelial carcinoma were positive for
myogenin, negative for cytokeratin and chromogranin stains. In contrast, small cell carcinoma was positive for
cytokeratin, and 7 out of 9 cases were also positive for chromogranin. Both rhabdomyosarcoma and small cell
carcinoma could be positive for synaptophysin, a potential pitfall to avoid. In addition, all of the tumors with
rhabdomyosarcomatous differentiation were negative for FKHR rearrangement.
Introduction
Rhabdomyosarcoma occurs much more commonly in
children than in adults in genitourinary tract, in which
more than 90% is embryonal, mostly botryoid type.
Adult rhabdomyosarcoma is extremely rare [1-7].
Because of its rarity in adults, proper diagnosis and clas-
sification can be a challenge. To make this matter more
complicated, rhabdomyoblastic differentiation is one of
commonly seen heterologous elements in sarcomatoid
carcinoma of urinary bladder [7]. Adult rhabdomyosar-
coma of urinary bladder can have morphologic features
overlapping with small cell carcinoma and poorly differ-
entiated urothelial carcinoma with rhabdomyoblastic dif-
ferentiation [7]. In this report, we reported three cases
of primary rhabdomyosarcomatous tumor of the urinary
bladder, two of them were diagnosed as carcinoma with
extensive rhabdomyosarcomatous differentiation based
on very minor carcinomatous elements identified and
one as rhabdomyosarcoma without carcinomatous ele-
ments identified in the tissue examined. In addition, we
compared the histologic and immunohistochemical fea-
tures of these urinary bladder tumors with rhabdomyo-
sarcomatous differentiation to that of well characterized
bladder small cell carcinoma.
Material and methods
The database of the Department of Pathology and
Laboratory Medicine of the University of Pennsylvania
was searched for bladder rhabdomyosarcoma, carcinoma
with rhabdomyosarcomatous differentiation and small
cell carcinoma for the period 1987-2010. One case of
rhabdomyosarcoma and two cases of poorly differen-
tiated urothelial carcinoma with extensive rhabdomyosar-
comatous differentiation were identified, and the medical
charts were reviewed and reported. In addition, 8 cases of
pure bladder small cell carcinoma and 5 cases of poorly
differentiated urothelial carcinoma with areas of small
cell carcinoma were retrieved for the study. All speci-
mens were fixed in a 10% neutral-buffered formalin solu-
tion and processed routinely. Histologic sections were
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selected for immunohistochemical study. This research
was approved by the University of Pennsylvania Institu-
tional Review Board.
Immunohistochemistry
Immunohistochemical stain was performed on formalin-
fixed, paraffin-embedded 4-um tissue sections with the
avidin-biotin immunoperoxidase complex method
(LSAB2 system, Dako Corporation, Carpinteria, Calif)
with diaminobenzedine as the chromogen and hematox-
ylin as the nuclear counterstain. Information about the
antibodies used was summarized in Table 1. Antigens
retrieval was done by incubating the tissue sections in a
Black and Decker Vegetable Steamer for 20 minutes in
Target Retrieval Solution (Dako) preheated to 99°C. The
negative control was performed by substituting the pri-
mary antibody with nonimmune mouse or rabbit serum.
Approximate positive controls were used.
FISH
FISH assay for translocation involving EWS and FHKR
was performed on paraffin sections using Vysis breaka-
part probes (Vysis) according to the manufacture’sp r o -
cedure guidelines.
Case histories and pathology
Primary bladder tumors with rhabdomyosarcomatous
differentiation: tumor with pure rhabdomyoblastic dif-
ferentiation a.k.a rhabdomyosarcoma (case 1) versus
tumor with minor carcinomatous element, a.k.a rhabdo-
myosarcomatous carcinoma (cases 2 and 3).
The clinical and histological features were summarized
in table 2 and 3. All are adult patient (one male and two
female). All presented with hematuria, two underwent
cystectomy and the third one underwent transurethral
resection of bladder tumor (TURBT) twice. The tumors
were exophytic and measured 3.2 cm in case 1 and 25 cm
in case 2 in the cystectomy specimens. In case 3 the sec-
ond TURBT was performed in this institution and con-
sisted of tumoral tissue in fragments in three parts
measuring 5.5 × 5.5 × 1.0 cm, 2.5 × 2.5 × 0.5 cm and
3.0 × 3.5 × 0.7 cm in aggregates respectively, with largest
fragments measuring 1.6 cm, 1.7 cm and 1.7 cm respec-
tively. All three tumors showed areas of small round cell
morphology with brisk mitosis and uniformly small
nuclei with no prominent nucleoli (Figure 1A, B). The
pure rhabdomyosarcoma (Case 1) showed no apparent
rhabdomyoblasts, while case 2 showed extensive rhabdo-
myoblastic features and case 3 showed focal rhabdomyo-
blastic features (Figure 1D). In addition to prominent
small round cell feature, all of the three cases exhibited
scattered marked nuclear anaplasia (Figure 1A, B) and
pleomorphism and patchy coagulative necrosis. No dis-
tinct alveolar pattern is seen. No carcinomatous element
was identified in pure rhabdomyosarcoma in 25 sections
of the 3.2 cm tumor, and the carcinomatous elements
were very focal in other two cases (Figure 1C). In case 2,
rare neoplastic epithelial cells were seen in pagetoid
spread in the overlying urothelium in extensive sampling
of this large tumor in one out of 46 sections. In case 3,
very focal invasive urothelial carcinoma component was
identified only in the initial TURBT specimen and not in
the second TURBT specimens despite the fact that all of
the tissue was submitted for histologic evaluation.
Tumors in case 1 and 2 showed deep invasion into peri-
vesicular tissue with lymph node metastasis.
Bladder tumors with small cell carcinoma compo-
nent: Pure small cell carcinoma and poorly differen-
tiated urothelial carcinoma with small cell carcinoma
components.
There is no morphologic difference in the small cell
carcinoma components between pure small cell carci-
noma and poorly differentiated urothelial carcinoma
with small cell carcinoma components. The tumors
were composed of loosely arranged sheets and nests of
small round blue cells with brisk mitosis and salt pepper
chromotins (Figure 2B). Nuclear anaplasia was common.
No rhabdomyoblastic differentiation is identified. The
only difference was that areas of poorly differentiated
conventional urothelial carcinoma were seen in the lat-
ter group.
Immunohistochemical study
Immunohistochemical studies with adequate controls
were performed and the results were summarized in
table 4. As shown in the table, the rhabdomyosarcoma-
tous areas of all of three rhabdomyosarcomatous tumors
of the bladder showed positivity for myogenin and
Table 1 Antibodies
Antibody Type Manufacturer Dilution
Myogenin Mouse
monoclonal
Dako 1:200
AE1/3 Mouse
monoclonal
Novacastra
Laboratories
1:400
Pan-CK Mouse
monoclonal
Novacastra
Laboratories
1:50
Chromogranin Rabbit polyclonal Zymed/Invitrogen 1:100
Synaptophysin Rabbit polyclonal Zymed/Invitrogen 1:50
Table 2 Clinical features
Case No. Age (years)/Gender Clinical presentation Treatment
1 61/Female Hematuria Cystectomy
2 58/Male Hematuria Cystectomy
3 57/Female Hematuria TURBT
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myosarcomatous carcinoma (carcinoma with extensive
rhabdomyosarcomatous differentiation) showed similar
extensive myogenin positivity (Figure 2E). No cytokera-
tin (Figure 2C) or chromogranin reactivity was detected
in the rhabdomyosarcomatous areas of these tumors.
Cytokeratin reactivity was only restricted to the rare
pagetoid carcinomatous cells in case 2 and focal urothe-
lial carcinoma in the case 3. Interestingly, Two out of
t h r e et u m o r s( c a s e1a n d2 )w e r ea l s od i f f u s e l yp o s i t i v e
for synaptophysin (Figure 2G), but negative for chromo-
granin. Six out of 8 pure small cell carcinoma of the
bladder and 3 out of 5 small cell carcinoma components
in poorly differentiated urothelial carcinoma were evalu-
ated for cytokeratin, chromogranin and synaptophysin
reactivity. All cases tested we r ep o s i t i v ef o rc y t o k e r a t i n
(Figure 2D). All but 2 were positive for chromogranin. 7
cases of small cell carcinoma and 2 case of small cell
carcinoma components of urothelial carcinoma were
also stained for synaptophysin and all were positive
Table 3 Histologic features
Case Size (cm) Carcinoma
Component
Mitosis
(HPF)
Necrosis Anaplasia Rhabdomyoblasts Depth of invasion Lymph node Metastasis
1 3.2 No 17 Yes Yes No perivesicular tissue 4/35
2 25 Yes 3 Yes Yes Yes (diffuse) PVT 1/1
3 4 (ultrasound) Yes (very focal) 9 Yes Yes Yes At least detrusor muscle N/A
Figure 1 Morphology of primary bladder rhabdomyosarcoma and bladder tumor with extensive rhabdomyosarcomatous and focal
epithelial differentiation, H&E, 400x. A. Primary rhabdomyosarcoma with anaplasia. B, C, D. Bladder tumor with extensive
rhabdomyosarcomatous differentiation and focal epithelial differentiation showing anaplasia 400x (B), focal epithelial differentiation (C),
rhabdomyoblastic differentiation (D).
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component from the pure small cell carcinoma and
urothelial carcinoma with small cell carcinoma compo-
nents were negative for myogenin (Figure 2F).
FISH assays
No EWS and FHKR breakapart signals were detected in
any of three rhabdomyosarcomatous areas of the three
bladder tumors.
Discussion
RMS in the urinary bladder has been well documented
in children with the majority being embryonal, betryoid
type [8,9]. RMS in adult urinary bladder is rare, with
only scattered case reports or small series [2,6,7,10-15].
In the reported cases, the tumor usually occurs in older
patients with the average age of 63+/-13 years. There is
a predilection for men with a male to female ration
roughly 2:1.
Figure 2 Immunohistochemical profiles of primary urinary bladder rhabdomyosarcoma and small cell carcinoma (400x).A ,C ,E ,G ,
primary urinary bladder rhabdomyosarcoma. A, H&E; C. Cytokeratin A/E1/3; E. Myogenin; G. Synaptophysin; B, D, F, H, small cell carcinoma of the
urinary bladder. B. H&E; D. Cytokeratin AE1/3; F. Myogenin; H. Synaptophysin.
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with high nuclear cytoplasm ratio, brisk mitosis and fre-
quent apoptosis. Frequently the tumors show nuclear
anaplasia, with random large anaplastic cells scattered in
the tumor, similar to the nuclear anaplasia seen in the
Wilm’s tumor without the requirement of tripolar atypi-
cal mitosis [16]. RMS in adult urinary bladders has been
reported to be alveolar [7,14,17], embryonal [11-13,17],
pleomorphic [2,6] type or unspecified [10].
Rhabdomyoblastic morphology may not be present in
t h et u m o r ;t h e r e f o r ei tm a yb ec o n f u s e dw i t ho t h e rp r i -
mitive tumors, especially with small cell carcinoma. On
the other hand, variable aberrant rhabdomyoblastic dif-
ferentiation could be seen in poorly differentiated urothe-
lial carcinoma. Typically, differential diagnosis of RMS in
adults includes sarcomatoid urothelial carcinoma with
extensive rhabdomyosarcomatous differentiation and
other tumors with small round cell morphology including
small cell carcinoma, plasmacytoid urothelial carcinoma,
primitive neuroectodermal tumor and lymphoma. Immu-
nohistochemical analysis has an important role in the
differential diagnosis of these tumors. Desmin and myo-
genin immunoreactivity can be used to differentiate rhab-
domyosarcoma from other round cell tumors without
rhabdomyoblastic differentiation but not sarcomatoid
carcinoma with rhabdomyoblastic differentiation. In
practice, urothelial carcinoma with extensive rhabdomyo-
sarcomatous differentiation c a no n l yb ed i f f e r e n t i a t e d
from de novo rhabdomyosarcoma based on finding of
any carcinomatous (neoplastic epithelial) element and/or
unequivocal cytokeratin immunoreactivity in tumor cells.
Therefore, sufficient sampling and mapping of tumor to
look for any carcinomatous element, in-situ or invasive,
are critical for making the distinction between these two
entities. The diagnostic difficulties are reflected in two of
our cases. In case 2, the tumor is very large (25 cm) and
only very small focus showing carcinomatous differentia-
tion. In case 3, small focus of urothelial carcinoma was
only identified in the initial TURBT specimen. In the
subsequent TURBT, no carcinomatous component was
identified albeit the whole specimen was entirely sub-
mitted in 15 cassettes for histologic evaluation. One can
conceive that when the carcinomatous element is very
small and/or dominated or replaced by rhabdomyosarco-
matous element, the minor carcinomatous element
might not be morphologically detectable easily in routine
sampling. In addition, as seen in these two cases, the
rhabdomyoblastic element could also lose their other
epithelial characteristics such as cytokeratin reactivity. In
such case, diagnosis of de novo rhabdomyosarcoma is
basically a function of extensiveness of tissue sampling
except for alveolar rhabdomyosarcoma for which mole-
cular analysis for PAX3/7-FHKR translocation can be
used to confirm the diagnosis. As illustrated in our cases,
majority of the rhabdomyoblastic tumors of the bladder
are likely rhabdomyosarcomatous carcinoma as small
foci of carcinomatous element are only detectable
through extensive sampling of the single or multiple spe-
cimens and pure rhabdomyoblastic tumor (a.k.a de novo
rhabdomyosarcoma) is very rare and the diagnosis should
be made with extreme caution.
The other challenge is differentiating rhabdomyosar-
coma and rhabdomyoblastic carcinoma from small cell
carcinoma. As some previous studies showed [7], we also
find that there is significant overlapping of morphologic
features between small cell carcinoma, rhabdomyosar-
coma and carcinoma with extensive rhabdomyoblastic
differentiation in urinary bladder. Small cell carcinoma of
bladder is a rare tumor with incidence reported between
0.5% and 1% of the bladder cancers in retrospective stu-
dies [18-20]. It can coexist with urothelial carcinoma. It
has been shown that similar patterns of allelic loss in the
small cell carcinoma component coexisting with urothe-
lial carcinoma. The similar patterns of allelic loss leads to
the hypothesis that these cells have common clonal ori-
gin [21]. The prognosis for small cell carcinoma of the
urinary bladder is poor, with overall 1-year and 5-year
disease-specific survival rates of 56% and 16% respec-
tively [19]. The treatment for bladder small cell carci-
noma is not standardized. However, chemotherapy
played a prominent role in the management of these
tumors [22]. Recent development includes the use of
adjuvant platinum-based chemotherapy for advanced dis-
ease. For adult bladder RMS, treatments are variable,
including surgical resection, radiotherapy, chemotherapy
or combined therapy. Prognostic markers with a worse
Table 4 Immunohistochemical study of Rhabdomyosarcomatous tumors and small cell carcinoma
Cases Number of
cases
Myogenin Cytokeratin Synaptophysin Chromogranin FISH in
RMS
RMS* 1 Positive Negative Positive Negative negative
RMS in ca^ 2 Positive in
RMS
Negative in RMS; positive in
ca
Positive in RMS in 1 out of 2
cases
Negative negative
Small cell
carcinoma
13 Negative Positive (9/9) Positive(9/9) Positive in 7/9 N/A
FISH DNA breakapart signal analysis for detection of translocation associated with EWS and FHKR.
*RMS: Rhabdomyosarcoma or rhabdomyosarcomatous component in appropriate setting; ^ca: Carcinoma.
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invasion and tumor size > 5 cm in children’ RMS [23].
Management of carcinoma with extensive rhabdomyosar-
comatous differentiation is not well defined. The pre-
ferred treatment appears to be cystectomy followed by
radiation therapy or chemotherapy [24].
Due to the difference in management, proper classifica-
tion of the rhabdomyoblastic tumors in bladder and dif-
ferentiate these tumors from morphologic mimics such
as small cell carcinoma are important. In this study, we
compared the expression of cytokeratin, myogenin,
synaptophysin and chromogranin in rhabdomyosarcoma-
tous tumor and small cell carcinoma of the bladder. As
shown in Table 4, areas of rhabdomyosarcomatous differ-
entiation were positive for desmin and myogenin, nega-
tive for cytokeratin and chromogranin in all cases. In this
study, we reported strong positivity for synaptophysin
detected in the RMS component of one of the sarcoma-
toid carcinomas, which was not reported previously. As
reported [7], positivity for synaptophysin can also be
detected in pure RMS, and hence has little utility to dif-
ferentiate rhabdomyosarcomatous tumors from other
mimics with neuroendocrine differentiation such as small
cell carcinoma. In contrast, small cell carcinoma compo-
nents, whether it is pure or admixed with urothelial car-
cinoma, were positive for cytokeratin and largely positive
for chromogranin, and negative for myogenin. FISH ana-
lysis was performed on paraffin-embedded formalin-fixed
tissue in three cases of rhabdomyosarcomatous tumor of
the bladder tumors to detect rearrangement of the FKHR
(13q14) region which is hallmark of alveolar rhabdomyo-
sarcoma. No FKHR rearrangement was detected in any
of these three cases. The negativity for such arrange-
ments does not support the diagnosis of alveolar type of
rhabdomyosarcoma. Primary de novo rhabdomyosar-
coma of any type is very rare in adult bladder. In this set-
ting, only alveolar rhabdomyosarcoma can be reliably
diagnosed by molecular test for PAX3 or 7-FKHR trans-
location. If the tumor is negative for PAX3 or 7-FKHR
translocation and lack of morphologic pleomorphism,
most of rhabdomyosarcomatous tumors arising from
adult bladder are likely of rhabdomyosarcomatous carci-
noma, a form of sarcomatoid carcinoma. Embryonal
rhabdomyosarcomas can arise in bladder wall in pediatric
patient but are extremely rare in adult patient. Clear
morphologic differential separation of de novo embryonal
rhabdomyosarcoma from those rhabdomyosarcomatous
carcinomas would be a challenge and depend upon one’s
will to search for evidence of carcinoma in specimen.
Unless a molecular test reveals evidence of alveolar rhab-
domyosarcoma, tumors with extensive rhabdomyosarco-
matous differentiation of the adult bladder should be
either classified as rhabdomyosarcomatous sarcomatoid
carcinoma when epithelial differentiation is identified or
rhabdomyosarcomatous tumor of the bladder when no
epithelial differentiation can be detected after reasonable
effort to search such evidence in a caveat that there is no
standard for what is considered reasonable effort in eval-
uating such specimen. Such diagnostic approach
acknowledges the difficulty in making morphologic dif-
ferentiation between rare occurring de novo soft tissue
rhabdomyosarcoma and rhabdomyosarcomatous sarco-
matoid carcinoma in adult patients.
In summary, pure RMS is very rare in adult urinary
bladder while rhabdomyosarcomatous sarcomatoid carci-
noma is more common. Adequate sampling, search for
admixed in-situ or invasive urothelial carcinoma and use
of cytokeratin stain may help to reach a correct diagnosis.
A descriptive diagnosis of rhabdomyosarcomatous tumor
of the bladder is preferred in difficult cases. Rhabdomyo-
sarcoma and rhabdomyosarcomatous sarcomatoid carci-
noma can be differentiated from small cell carcinoma of
the bladder by immunohistochemical evaluation of cyto-
keratin and chromogranin and myogenin.
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